Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$59.26 - $71.14 $110,342 - $132,462
-1,862 Reduced 32.74%
3,826 $253,000
Q1 2022

May 05, 2022

SELL
$55.72 - $67.12 $49,869 - $60,072
-895 Reduced 13.6%
5,688 $377,000
Q4 2021

Jan 28, 2022

BUY
$54.02 - $63.83 $355,613 - $420,192
6,583 New
6,583 $383,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $220B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Dgs Capital Management, LLC Portfolio

Follow Dgs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dgs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dgs Capital Management, LLC with notifications on news.